May 30, 2023
|The Honorable Jason Smith||The Honorable Richard Neal|
|House Committee on Ways & Means||House Committee on Ways & Means|
|1139 Longworth House Office Building||1139 Longworth House Office Building|
|Washington, D.C. 20515||Washington, D.C. 20515|
Re: MGMA Testimony — “Health Care Price Transparency: A Patient’s Right to Know”
Dear Chairman Smith and Ranking Member Neal:
On behalf of our member medical group practices, the Medical Group Management Association (MGMA) would like to thank the Committee for holding this important hearing on “Health Care Price Transparency: A Patient’s Right to Know” and appreciate the opportunity to provide feedback on this important topic.
With a membership of more than 60,000 medical practice administrators, executives, and leaders, MGMA represents more than 15,000 group medical practices ranging from small private medical practices to large national health systems representing more than 350,000 physicians. MGMA’s diverse membership uniquely situates us to offer the following policy recommendations as the Committee and lawmakers consider healthcare price transparency solutions.
The No Surprises Act established critical patient protections against balance billing and created new cost transparency tools to help empower patients to be better informed while making healthcare decisions. On Jan. 1, 2022, several provisions of the No Surprises Act took effect, including the uninsured and self-pay good faith estimate (GFE) requirements. Although MGMA supports the spirit of the law, we have concerns about the way certain provisions will be implemented due to the limitations of the current healthcare environment and available infrastructure.